Tonix Pharmaceuticals Holding Corp

TNXPNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

16.8M

on 2026-06-30, from 27K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-28 and 1-for-99 reverse splits; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$500.0M

S-3 of 2025-06-12. 1 prospectus supplement filed under it since. S-3 ↗

$150.0M

Agreement of 2024-07-30. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

641K

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

4.6 quarters

$176.2M on 2026-06-30 ÷ $38.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-12-29	Public offering incl. 0.62M pre-funded	1,230,050	$16.26	not read	424B5 ↗
2025-12-29	Registered direct offering incl. 0.62M pre-funded	1,230,050	not read	$20.0M	8-K ↗
2025-11-21	Public offering	not read	not read	not read	424B5 ↗
2025-06-11	Public offering	not read	not read	not read	424B5 ↗